Literature DB >> 19394601

Eutopic endometrial interleukin-18 system mRNA and protein expression at the level of endometrial-myometrial interface in adenomyosis patients.

Hong-Yuan Huang1, Hsing-Tse Yu, She-Hung Chan, Chyi-Long Lee, Hsin-Shih Wang, Yung-Kuei Soong.   

Abstract

OBJECTIVE: To investigate the eutopic endometrial interleukin-18 (IL-18) system including interleukin-18 (IL-18), IL-18 receptor (IL-18R), and IL-18 binding protein (IL-18BP), mRNA, and protein expression in patients with adenomyosis.
DESIGN: A clinical and molecular study.
SETTING: Clinical and academic research setting in a university medical center. PATIENT(S): Twenty-eight samples of human eutopic endometria were obtained from surgical specimens of normal cycling women undergoing hysterectomy for uterine adenomyosis (n = 19); the control group (n = 9) was women undergoing hysterectomy for benign reason including uterine fibroids. INTERVENTION(S): Quantitative competitive polymerase chain reaction (QC PCR) and immunohistochemistry studies were performed. MAIN OUTCOME MEASUREMENT(S): The differences of the IL-18 system mRNA and the ratio of IL-18BP to IL-18 in the eutopic endometrium of uterine adenomyosis and control group were analyzed. RESULT(S): IL-18 system mRNA and protein expression was demonstrated in the eutopic endometrium of both adenomyosis and control women. Quantitative competitive PCR demonstrated that endometrial IL-18R mRNA and the ratio of IL-18BP to IL-18 were significantly increased in adenomyosis patients in comparison to the control group. Pearson's correlation showed a significant correlation between IL-18 and IL-18R in the eutopic endometrium of women with uterine adenomyosis, but not the control group. CONCLUSION(S): The expression of the eutopic endometrial IL-18 system and the ratio of antagonist to agonist at the level of the endometrial-myometrial interface (EMI) may possibly be responsible for the pathologic process of adenomyosis. Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394601     DOI: 10.1016/j.fertnstert.2009.01.132

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Adenomyosis: Mechanisms and Pathogenesis.

Authors:  Junyu Zhai; Silvia Vannuccini; Felice Petraglia; Linda C Giudice
Journal:  Semin Reprod Med       Date:  2020-10-08       Impact factor: 1.303

2.  Immune-inflammation gene signatures in endometriosis patients.

Authors:  Soo Hyun Ahn; Kasra Khalaj; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade
Journal:  Fertil Steril       Date:  2016-07-27       Impact factor: 7.329

3.  Accumulation of nerve growth factor and its receptors in the uterus and dorsal root ganglia in a mouse model of adenomyosis.

Authors:  Yan Li; Shao-fen Zhang; Shi-en Zou; Xian Xia; Lei Bao
Journal:  Reprod Biol Endocrinol       Date:  2011-03-08       Impact factor: 5.211

4.  Increased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesity.

Authors:  Rasheed Ahmad; Puthiyaveetil Kochumon Shihab; Reeby Thomas; Munera Alghanim; Amal Hasan; Sardar Sindhu; Kazem Behbehani
Journal:  Diabetol Metab Syndr       Date:  2015-08-27       Impact factor: 3.320

5.  Serum Interleukin-18 and Its Gene Haplotypes Profile as Predictors in Patients with Diabetic Nephropathy.

Authors:  Ahmed I Abd Elneam; Nahla M Mansour; Nayel A Zaki; Mohamed A Taher
Journal:  Open Access Maced J Med Sci       Date:  2016-07-21

6.  CD83+ CCR7+ NK cells induced by interleukin 18 by dendritic cells promote experimental autoimmune uveitis.

Authors:  Qiang Fu; Xuejing Man; Xin Wang; Nannan Song; Yuanbin Li; Jiangnan Xue; Yufei Sun; Wei Lin
Journal:  J Cell Mol Med       Date:  2018-12-08       Impact factor: 5.310

Review 7.  Molecular Links between Central Obesity and Breast Cancer.

Authors:  Alina-Andreea Zimta; Adrian Bogdan Tigu; Maximilian Muntean; Diana Cenariu; Ondrej Slaby; Ioana Berindan-Neagoe
Journal:  Int J Mol Sci       Date:  2019-10-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.